MEDIFAST INC (MED): Results of Operations and Financial Condition
MEDIFAST INC (MED) filed an SEC Form 8-K — Results of Operations and Financial Condition. Medifast Announces Second Quarter 2026 Financial Results August 3, 2026 BALTIMORE – ( BUSINESS WIRE ) — Medifast (NYSE: MED), the health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy, today reported results for the second quarter
How this was made
The 30-second read
Why it matters
Key trading inputs are the magnitude of revenue contraction driven by active earning coach declines, margin compression from lower volume and fixed-cost leverage, and management’s explicit loss and revenue guidance ranges for upcoming quarters.
Market read
This is a primary earnings-and-guidance disclosure with operating-metric detail (active earning coaches, revenue per coach) and forward ranges that can reprice expectations immediately.
What to watch
Catalyst program execution is expected to drive cost savings in Q3, and the company is debt-free with $169.8M cash and investments, which may reduce balance-sheet risk even if losses persist.
Background
Medifast filed an 8-K with its Q2 2026 results (ended June 30, 2026) and provided updated outlook for Q3 and full-year 2026.
Ticker impact
Medifast reported Q2 2026 results and guided Q3 revenue to $60M-$80M and Q3 EPS loss to $0.15-$0.65.
Near-term volatility likely around the guidance ranges and coach-count trajectory, with downside risk if active coach declines persist.
The 8-K includes concrete financial prints (revenue, net loss) and forward guidance (Q3 and full-year 2026 revenue and EPS loss), which are direct inputs to valuation and expectations.
Market effects
Highlights ongoing demand and acquisition pressure for coach-led health and wellness models, with GLP-1 adoption cited as a headwind.
No specific regional spillover beyond company-level performance.
Limited global relevance; primarily company-specific guidance and operating metrics.
Counterpoint
The company frames the quarter as part of a turnaround, citing sequentially stable revenue and rising revenue per active coach, which could offset coach-count declines if productivity improvements continue.
Key entities
- public_companyMedifast, Inc.
Health and wellness company reporting Q2 2026 financial results and issuing Q3 and FY 2026 guidance.
- product_brandTrilivy
Brand referenced as part of the company’s 3.0 strategy and transformation.
- cost_programCatalyst program
Initiative designed to drive additional cost savings, with majority execution expected in Q3.
